Jean-Yves Pierga

Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University

Affiliated withInstitut Curie, PSL Research University University Paris Descartes

Research Area

Biography

Jean-Yves Pierga has not added Biography.
If you are Jean-Yves Pierga and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 7	2018

Other Publications

Article	Year
Treatment of malignant gliomas in the elderly. Journal of neuro-oncology\| PubMed ID: 10533732	1999
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. The Lancet. Oncology\| PubMed ID: 24636208	2014
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Molecular oncology\| PubMed ID: 25579085	2015
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial. Cancer letters\| PubMed ID: 25700777	2015
High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection. Lab on a chip\| PubMed ID: 25815443	2015
Clinical utility of circulating tumor cells in metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 25870091	2015
Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions. Expert review of molecular diagnostics\| PubMed ID: 26568208	2016
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort. British journal of cancer\| PubMed ID: 26657653	2016
Circulating tumor cells in breast cancer. Molecular oncology\| PubMed ID: 26809472	2016
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer. Molecular oncology\| PubMed ID: 26856794	2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nature communications\| PubMed ID: 27406316	2016
FISH-in-CHIPS: A Microfluidic Platform for Molecular Typing of Cancer Cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 28044298	2017
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Clinical chemistry\| PubMed ID: 28073896	2017
Circulating tumor cells: clinical validity and utility. International journal of clinical oncology\| PubMed ID: 28238187	2017
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib ... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28279941	2017
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28351929	2017
RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28743036	2017
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clinical chemistry\| PubMed ID: 29122835	2018
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast cancer research and treatment\| PubMed ID: 29374852	2018
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. Journal of the National Cancer Institute\| PubMed ID: 29659933	2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab. Breast (Edinburgh, Scotland)\| PubMed ID: 29913374	2018
Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer. NPJ breast cancer\| PubMed ID: 29951582	2018
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy. Nature reviews. Clinical oncology\| PubMed ID: 30050094	2018
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30054279	2018